Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYA for postprandial glucose control in type 1 diabetes (T1DM-HYA)
jRCTs051220104Active, not recruiting
- Sponsor
- Noster
- Start
- Dec 2022
- Countries
- 1
01
Overview
Randomised, single-blind trial of hyaluronic acid in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Noster. Primary endpoint: Change in blood glucose from pre-intervention to 90 minutes post-meal. Started Dec 2022; status: active, not recruiting.
02
Drugs
hyaluronic acid
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on jRCTs051220104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051220104.